Bart Cobert discusses the importance of clinical safety reporting. Not only is this a legal responsibility but also an ethical one.
Bart Cobert addresses the use of marijuana for medical purposes and the implications for Drug Safety.
What information should be examined in the study and work up of ADRs to determine whether the reaction is likely due to the drug or not.
The greatest change AI will bring about in healthcare is the enabling of clinicians to make sense of the mind-boggling amount of patient data being generated every day.
Bart Cobert reviews the changes and updates happening with UK and EMA inspections.
Voice Assistants may just be the key to solving the challenge of patient non-compliance.
Patient engagement technology is critical to the needs of the pharmaceutical industry, and thus, patient centric clinical trials are the way forward.
We participate in safety reporting not only because it is required by law, but because we are HCPs whose first duty is always to protect the patient.
An update on the status of Brexit and the EMA move to Amsterdam.
The life sciences industry is striving to develop patient engagement through the use of AI-driven virtual assistant services.
Transitioning from Illness Management to Wellness Management: How can Healthcare Make Itself an Active Partner in Consumers’ Lifestyle Transformation?
Bart Cobert addresses confusing areas in Drug Safety and Pharmacovigilance including Brexit, basic terminology, date formatting and others.